{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:22:49Z","timestamp":1774567369239,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:00:00Z","timestamp":1378166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12282-013-0493-z","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T07:38:29Z","timestamp":1378107509000},"page":"399-405","source":"Crossref","is-referenced-by-count":10,"title":["Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women"],"prefix":"10.1007","volume":"22","author":[{"given":"Yoshimasa","family":"Miyagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetoshi","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Kotoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hatada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Sasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"key":"493_CR1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, et al. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558\u201368.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"493_CR2","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/bcr1525","volume":"8","author":"H Ma","year":"2006","unstructured":"Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8:R43.","journal-title":"Breast Cancer Res"},{"key":"493_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/87.3.190","volume":"87","author":"PG Toniolo","year":"1995","unstructured":"Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995;87:190\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR4","doi-asserted-by":"crossref","unstructured":"Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer. 1997;75:1075\u20139.","DOI":"10.1038\/bjc.1997.183"},{"key":"493_CR5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","volume":"90","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u20131578.","journal-title":"Lancet"},{"key":"493_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","volume":"4","author":"M Harvie","year":"2003","unstructured":"Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev. 2003;4:157\u201373.","journal-title":"Obes Rev"},{"key":"493_CR8","first-page":"213","volume":"78","author":"A Schatzkin","year":"1987","unstructured":"Schatzkin A, Palmer JR, Rosenberg L, et al. Risk factors for breast cancer in black women. J Natl Cancer Inst. 1987;78:213\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-08-0206","volume":"17","author":"AI Phipps","year":"2008","unstructured":"Phipps AI, Malone KE, Porter PL, et al. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17:2078\u201386.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"493_CR10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.23943","volume":"124","author":"R Suzuki","year":"2009","unstructured":"Suzuki R, Orsini N, Saji S, et al. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status\u2013a meta-analysis. Int J Cancer. 2009;124:698\u2013712.","journal-title":"Int J Cancer"},{"key":"493_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"493_CR12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1349-7006.2011.01867.x","volume":"102","author":"M Toi","year":"2011","unstructured":"Toi M, Saji S, Masuda N, et al. Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24\u00a0weeks of aromatase inhibition. Cancer Sci. 2011;102:858\u201365.","journal-title":"Cancer Sci"},{"key":"493_CR13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","volume":"95","author":"TJ Key","year":"2003","unstructured":"Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Endogenous Hormones Breast Cancer Collaborative Group. J Natl Cancer Inst. 2003;95:1218\u201326.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008929714862","volume":"12","author":"PK Verkasalo","year":"2001","unstructured":"Verkasalo PK, Thomas HV, Appleby PN, et al. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control. 2001;12:47\u201359.","journal-title":"Cancer Causes Control"},{"key":"493_CR15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djh216","volume":"96","author":"AS Furberg","year":"2004","unstructured":"Furberg AS, Veier\u00f8d MB, Wilsgaard T, et al. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004;96:1152\u201360.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101:48\u201360.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12282-008-0042-3","volume":"15","author":"R Nishimura","year":"2008","unstructured":"Nishimura R, Arima N. Is triple negative a prognostic factor in breast cancer? Breast Cancer. 2008;15:303\u20138.","journal-title":"Breast Cancer"},{"key":"493_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101:736\u201350.","journal-title":"J Natl Cancer Inst"},{"key":"493_CR19","first-page":"289","volume":"6","author":"CJ Creighton","year":"2012","unstructured":"Creighton CJ. The molecular profile of luminal B breast cancer. Biologics. 2012;6:289\u201397.","journal-title":"Biologics"},{"key":"493_CR20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.2010.31.6950","volume":"29","author":"MJ Ellis","year":"2011","unstructured":"Ellis MJ, Suman VJ, Hoog J, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype\u2013ACOSOG Z1031. J Clin Oncol. 2011;29:2342\u20139.","journal-title":"J Clin Oncol"},{"key":"493_CR21","doi-asserted-by":"crossref","unstructured":"Murase K, Yanai A, Saito M, et al. Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer. 2012. doi: 10.1007\/s12282-012-0348-z .","DOI":"10.1007\/s12282-012-0348-z"},{"key":"493_CR22","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/bcr3186","volume":"14","author":"R Ritte","year":"2012","unstructured":"Ritte R, Lukanova A, Berrino F, et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res. 2012;14:R76.","journal-title":"Breast Cancer Res"},{"key":"493_CR23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ijc.25744","volume":"129","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Iwasaki M, Inoue M, et al. Body weight at age 20\u00a0years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status\u2013the Japan public health center-based prospective study. Int J Cancer. 2011;129:1214\u201324.","journal-title":"Int J Cancer"},{"key":"493_CR24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103:250\u201363.","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-013-0493-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0493-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T07:38:33Z","timestamp":1688456313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-013-0493-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1007\/s12282-013-0493-z","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}